U.S. health care workers were most likely to be infected with COVID-19 at work during the pandemic’s first year, according to a new study that challenges previous research suggesting their risk was highest off the job. Researchers said their findings could help guide efforts to better protect health care workers during future infectious disease outbreaks. “This study provides important insights to guide infection prevention and control practices in health care settings so that we can better protect HCPs [health care professionals] and their patients,” said Linda Dickey, president of the Association for Professionals in Infection Control and Epidemiology (APIC), which published the findings in its journal. For the study, researchers analyzed data from the U.S. Centers for Disease Control and Prevention on nearly 84,000 health care workers who were diagnosed with COVID-19 between March 1, 2020, and March 31, 2021, and whose source of exposure was known. Exposure to SARS-CoV-2 was more likely in the workplace (52%) than in the home (nearly 31%) or community (about 26%). Workplace-associated exposures peaked in April 2020 at 84%, the researchers found. About two-thirds of health care workers who reported a specific type of on-the-job exposure said they’d come into contact with patients or other health care workers who had COVID-19. The largest reductions in workplace exposures occurred in June 2020 after introduction of improved infection prevention and control…  read on >  read on >

So, the new year has begun and everyone is trying to losing weight, but what is the best way to determine how many pounds you need to shed — BMI or body fat? “Both body fat percentage and BMI are important to monitor. They give you a good starting point, but you don’t want to use BMI alone to make a health diagnosis or define body fat,” said Claire Edgemon, a senior registered dietitian at Baylor College of Medicine in Houston. “If BMI is used alone, it could be misleading about an individual’s health status.” Why is BMI a less accurate measure of body fat? It only tracks a person’s weight compared to their height, but that doesn’t include muscle, bone or fat mass. And since BMI doesn’t measure what is going on metabolically, blood pressure, blood sugar and cholesterol levels should also be measured, Edgemon noted. In contrast to BMI, percentage of body fat determines how much of a person’s weight is fat. A quick way to measure body fat comes down to the circumference of the waist. Over 35 inches for women and over 40 inches for men points to more abdominal fat and greater health risks, Edgemon said. “There is a healthy range for body fat percentage, but there are differences to consider, like age or gender. A healthy body fat range…  read on >  read on >

Folks who take Ozempic or Wegovy for diabetes and weight loss need not worry about a higher risk of suicidal thoughts or feelings while on the medications, a new, large review finds. In the study, which was funded by the U.S. National Institutes of Health, researchers turned to a database of more than 100 million patient records to measure the risks of suicidal ideation among people using semaglutide, which is sold as Ozempic for type 2 diabetes and Wegovy for weight loss. The results were published Jan. 5 in the journal Nature Medicine. Study author Dr. Rong Xu, a professor of biomedical informatics at Case Western Reserve University School of Medicine in Cleveland, told CNN that she decided to look into the issue after European regulators opened a probe into semaglutide and reports of suicidal thoughts last summer. Just this week, a quarterly report from the U.S. Food and Drug Administration revealed that the agency is looking into similar reports among users of multiple weight-loss drugs, including Ozempic and Wegovy. For the new review, Xu and her team, which included National Institute on Drug Abuse Director Dr. Nora Volkow, compared cases of suicidal ideation among people taking semaglutide with those taking other medicines for weight loss or diabetes. “We observed a lower incidence of suicidal ideations in patients who had taken semaglutide than in patients who were treated with non-GLP1R-targeting…  read on >  read on >

How much a person believes in the strength of a drug might influence how powerfully that drug influences brain activity, a new study has found. Smokers told to expect a low, medium or high dose of nicotine from an e-cigarette showed a brain response that tracked with the purported dose, even though nicotine levels were actually constant, researchers said.  “We set out to investigate if human beliefs can modulate brain activities in a dose-dependent manner similar to what drugs do, and found a high level of precision in how beliefs can influence the human brain,” said senior researcher Xiaosi Gu. She’s an associate professor of psychiatry and neuroscience at the Icahn School of Medicine at Mount Sinai, in New York City. For the study, Gu and her team recruited a group of people hooked on nicotine and had them puff on an e-cigarette, after telling them how powerful a nicotine dose they should expect. The participants then underwent brain scans while performing a decision-making task known to engage parts of the brain affected by nicotine. “Beliefs can have a powerful influence on our behavior, yet their effects are considered imprecise and rarely examined by quantitative neuroscience methods,” Gu noted in a Mount Sinai news release. The thalamus — an important binding site for nicotine in the brain — showed a dose-dependent response to each person’s…  read on >  read on >

Migraines are not only extremely painful, but they also appear to pose a driving risk for seniors, a new study warns. Older adult drivers recently diagnosed with migraines are three times more likely to be involved in a car crash, researchers reported recently in the Journal of the American Geriatrics Society. “Migraine headaches affect more than 7% of U.S. adults over the age of 60,” noted lead researcher Dr. Carolyn DiGuiseppi, a professor with the University of Colorado School of Public Health. “The U.S. population is aging, which means increasing numbers of older adult drivers could see their driving abilities affected by migraine symptoms previously not experienced,” DiGuiseppi added in a university news release. “These symptoms include sleepiness, decreased concentration, dizziness, debilitating head pain and more.” For the study, researchers tracked more than 2,500 drivers ages 65 to 79 in five sites across the United States. A previous diagnosis of migraine did not appear to influence a driver’s crash risk, results show. But a new migraine diagnosis brought with it a threefold increase in the risk of a wreck within a year, researchers found. Medications commonly prescribed for migraines did not appear to influence either crash risk or driving habits, the researchers noted. “These results have potential implications for the safety of older patients that should be addressed,” DiGuiseppi said. “Patients with a new migraine…  read on >  read on >

The U.S. Food and Drug Administration is investigating reports of additional dangers linked to several wildly popular weight-loss drugs. In a quarterly report issued this week, the agency said it is investigating cases of hair loss; aspiration (when food or other objects get into the airways); and suicidal ideation in people who used the medications. Some of the drugs in this class, known as GLP-1 receptor agonists (GLP-1 RA), include Ozempic, Wegovy, Mounjaro and Zepbound. While these reports can turn out to be false alarms, previous investigations have prompted the FDA to update a drug’s labeling or call for additional study on the issue. This isn’t the first time the agency has looked into potential complications with these weight-loss drugs: Last year, the agency investigated reports of intestinal obstructions linked to the medications. Ozempic’s labeling was subsequently updated to acknowledge that risk, CBS News reported.  “We are aware that, as part of those monitoring efforts, [the] FDA is evaluating several potential signals related to GLP-1 RA medicines and has posted information about those ongoing assessments on its website,” a spokesperson for Novo Nordisk, which makes Ozempic and Wegovy, told CBS News. “Novo Nordisk stands behind the safety and efficacy of all of our GLP-1 RA medicines when they are used as indicated and when they are taken under the care of a licensed healthcare professional,” the spokesperson added.…  read on >  read on >

An electrical zap to the brain can temporarily render a person more susceptible to hypnosis, a new study shows. Participants became more easily hypnotized after paddles placed against their scalp delivered two 46-second rounds of electrical pulses to a precise location in their brain, researchers reported Jan. 4 in the journal Nature Mental Health. This increase in their susceptibility to hypnosis lasted for about an hour, results show. These findings could make hypnotherapy a viable treatment for people who otherwise couldn’t be deeply tranced, the researchers said. “We know hypnosis is an effective treatment for many different symptoms and disorders, in particular pain,” said lead researcher Afik Faerman, a postdoctoral scholar in psychiatry at Stanford Medicine. “But we also know that not everyone benefits equally from hypnosis.” About two-thirds of adults are at least somewhat prone to hypnosis, and 15% are considered highly hypnotizable, researchers said in background notes. “Hypnosis is a state of highly focused attention, and higher hypnotizability improves the odds of your doing better with techniques using hypnosis,” senior researcher Dr. David Spiegel, a professor of psychiatry and behavioral sciences at Stanford, said in a university news release. Spiegel has studied hypnotherapy for decades, using it to help patients control pain, lower stress and stop smoking. Up to now, hypnotizability has seemed to be a stable trait in people that changes little…  read on >  read on >

Some people might be prone to low back pain because of specific cells contained in their spinal disks, a new study suggests. The research could explain why only certain people develop back pain due to the degeneration of their spinal discs, which are jelly-filled spacers that act as shock absorbers between the small bones of the vertebrae. “We’ve identified for the first time particular cells that could be the key to understanding disk pain,” said senior study author Dmitriy Sheyn, a research scientist in the Board of Governors Regenerative Medicine Institute at Cedars-Sinai Medical Center in Los Angeles. “Learning more about how these cells work could lead to the eventual discovery of new treatment options,” Sheyn added in a Cedars Sinai news release. About 40% of adults experience low back pain due to degenerating disks in the spine, but up to now it’s not been clear exactly why the disks become painful. The jelly in spinal disks tends to dry out and degenerate as people age, but that doesn’t automatically trigger back pain, the researchers noted. “This is because the inner jelly-like layers of the disks contain no nerve endings,” Sheyn said. “But sometimes, when disks degenerate, nerve endings from the surrounding tissues invade the disk, and we believe this causes pain.” For this study, researchers first compared spinal disks from patients with low back…  read on >  read on >

Glaucoma can steal your sight before you even realize it, and early diagnosis is the best way to prevent it. Many of the 3 million Americans who have glaucoma are unaware of it because they have no symptoms, according to the Glaucoma Foundation. In glaucoma, a buildup of fluid in the front part of the eye increases pressure and damages the optic nerve. Here are seven key facts to know about glaucoma:  Most forms of the disease have no symptoms and vision changes don’t happen right away. Once eyesight is lost, the damage is permanent Glaucoma can strike at any stage of life, not just in old age. In fact, about 1 baby in 10,000 is born with the condition While family history is a risk factor, just because your family doesn’t have glaucoma doesn’t make you risk-free. Everyone in the family should be tested if there’s a family history Black folks are six times more likely to have glaucoma than white Americans, and it starts years earlier, often with greater loss of vision. Asian people are also at high risk and glaucoma is more common among Hispanic Americans than once believed Elevated pressure inside the eye is a risk factor for glaucoma, not the disease itself. In some of the more than 40 forms of glaucoma, elevated eye pressure is not involved. The common…  read on >  read on >

A diet supplement derived from citrus fruits reduced swelling and pain after knee replacement surgery, a new clinical trial found. The flavonoid supplement, diosmin, could offer a new approach to painful swelling after the procedure, according to a team led by Dr. Pengde Kang of Sichuan University in Chengdu, China.  “Postoperative lower-extremity swelling is a major hindrance to the enhanced recovery of patients” after knee replacement, the researchers wrote recently in The Journal of Bone and Joint Surgery.  Various strategies, including rest, cold packs and compressive bandages, have had mixed success. And no medications are available to reduce post-operative swelling, the researchers noted. Diosmin — which is often combined with a related flavonoid called hesperidin — is used to reduce swelling in limbs of patients with disorders of the blood vessels. It is not approved as a prescription medication in the United States or Europe, but the researchers noted that experience suggests it is well-tolerated.  For the study, the team looked at 330 patients who had total knee replacement at 13 university-affiliated hospitals. They were randomly assigned to a treatment group that received a 14-day course of diosmin after surgery or to a control group that received no treatment. Both groups received standard pain medication.  Swelling at specific spots was measured four times after surgery and compared between the two groups. Pain scores, knee function,…  read on >  read on >